Evidence map›Paper›PMID 34470115›Full record

ArticleThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2022

Marijuana use, fetal growth, and uterine artery Dopplers.

Ann M Bruno, Nathan R Blue, Amanda A Allshouse, David M Haas, Anthony L Shanks, William A Grobman, Hyagriv Simhan, Uma M Reddy, Robert M Silver, Torri D Metz

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Ann M BrunoDepartment of Obstetrics & Gynecology, University of Utah Health, Salt Lake City, UT, USA.ORCID 0000-0002-3049-1467
Nathan R BlueDepartment of Obstetrics & Gynecology, University of Utah Health, Salt Lake City, UT, USA.
Amanda A AllshouseDepartment of Obstetrics & Gynecology, University of Utah Health, Salt Lake City, UT, USA.
David M HaasDepartment of Obstetrics & Gynecology, Indiana University, Indianapolis, IN, USA.
Anthony L ShanksDepartment of Obstetrics & Gynecology, Indiana University, Indianapolis, IN, USA.
William A GrobmanDepartment of Obstetrics & Gynecology, Northwestern University, Chicago, IL, USA.
Hyagriv SimhanDepartment of Obstetrics & Gynecology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Uma M ReddyDepartment of Obstetrics & Gynecology, Yale University, New Haven, CT, USA.
Robert M SilverDepartment of Obstetrics & Gynecology, University of Utah Health, Salt Lake City, UT, USA.
Torri D MetzDepartment of Obstetrics & Gynecology, University of Utah Health, Salt Lake City, UT, USA.
Intermountain Healthcare · USIndiana University Health · USNorthwestern University · USUniversity of Pittsburgh · USUniversity of Utah · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Utah Women's Reproductive Health Research Career Development ProgramK12HD085816 · NICHD · UNIVERSITY OF UTAH · PI SILVER, ROBERT M. · 2015 to 2024
$3.2M
Maternal Marijuana Use and Adverse Perinatal OutcomesR01DA049832 · NIDA · UNIVERSITY OF UTAH · PI METZ, TORRI D · 2020 to 2023
$2.5M
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002538NICHD NIH HHS K12 HD085816NIDA NIH HHS R01 DA049832
6 · The paper itself

Abstract

objectiveMarijuana (MJ) use is associated with adverse effects on fetal growth. We aimed to investigate the timing of suboptimal fetal growth onset in MJ-exposed pregnancies. In addition, we aimed to explore the relationship between MJ-exposure and both abnormal uterine artery (UtA) Doppler parameters and small for gestational age (SGA). STUDY

designThis was a secondary analysis of a prospective multicenter cohort that enrolled nulliparous individuals delivering non-anomalous fetuses beyond 20 weeks' gestation. Marijuana exposure was ascertained by self-report or clinical urine toxicology testing. Ultrasound estimated fetal weights (EFWs) were assessed in participants at both 16w0d-21w6d and 22w0d-29w6d. EFWs and birth weight (BW) were converted to weight percentiles (wPCT). EFW and BW wPCTs were calculated using population-based standards. Additionally, a customized standard designed to be applicable to both EFWs and BWs within the same model was also used to allow for EFW to BW percentile trajectories. The primary outcome, longitudinal wPCT, was compared between individuals with and without MJ use in a linear mixed-effects regression model adjusting for tobacco. For modeling, wPCT was smoothed across gestational age; MJ was estimated as an intercept and linear difference in the slope of gestational age. UtA Doppler notching, resistance index (RI), and pulsatility index (PI) at 16w0d-21w6d were compared using

resultsNine thousand one hundred and sixty-three individuals met inclusion criteria; 136 (1.5%) used MJ during pregnancy. Individuals who used MJ were more likely to be younger, identify as non-Hispanic Black, and have had less education. Fetuses exposed to MJ had lower wPCT beginning at 28 weeks using population-based and customized standards, when compared to those without exposure. UtA notching, PI, and RI were similar between groups. SGA was more frequent in neonates exposed to MJ using both population-based (22 vs. 9%,

conclusionsMJ-exposed fetuses were estimated to be smaller than unexposed fetuses starting at 28 weeks' gestation across both growth standards without a difference in UtA Doppler parameters.

Indexed as

Marijuana UseUterine ArteryBirth WeightFemaleFetal Growth RetardationFetal WeightGestational AgeHumansInfant, NewbornInfant, Small for Gestational AgePredictive Value of TestsPregnancyPregnancy Trimester, ThirdProspective StudiesUltrasonography, Prenatalbirth weightfetal growthMarijuanauterine artery Dopplerweight percentile

Identifiers

PMID34470115
PMCPMC9080638
OpenAlexW3197922916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.